Industry Research Reports

Home > Reports > Medical Devices & Consumables > Haemostat - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Haemostat - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-01-16

Pages: 98 Pages

Report ld: 2228629

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Haemostat was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Market Segmentation

By Company

Ethicon
CSL Behring
Pfizer
Equimedical BV
Davol
Baxter
Hemcon Medical Technologies
Ceremed

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Pituitrin
Hemostatic Sensitivity
Others

Segment by Application

Hospital
Clinic
ASCs
Others

biaoTi Report Scope

This report aims to provide a comprehensive presentation of the global market for Haemostat, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Haemostat by region & country, by Type, and by Application.

The Haemostat market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Haemostat.

biaoTi Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Haemostat manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Haemostat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Haemostat in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 Haemostat Product Introduction

1.2 Global Haemostat Market Size Forecast

1.2.1 Global Haemostat Sales Value (2019-2030)

1.2.2 Global Haemostat Sales Volume (2019-2030)

1.2.3 Global Haemostat Sales Price (2019-2030)

1.3 Haemostat Market Trends & Drivers

1.3.1 Haemostat Industry Trends

1.3.2 Haemostat Market Drivers & Opportunity

1.3.3 Haemostat Market Challenges

1.3.4 Haemostat Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Haemostat Players Revenue Ranking (2023)

2.2 Global Haemostat Revenue by Company (2019-2024)

2.3 Global Haemostat Players Sales Volume Ranking (2023)

2.4 Global Haemostat Sales Volume by Company Players (2019-2024)

2.5 Global Haemostat Average Price by Company (2019-2024)

2.6 Key Manufacturers Haemostat Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Haemostat Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Haemostat

2.9 Haemostat Market Competitive Analysis

2.9.1 Haemostat Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Haemostat Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemostat as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Pituitrin

3.1.2 Hemostatic Sensitivity

3.1.3 Others

3.2 Global Haemostat Sales Value by Type

3.2.1 Global Haemostat Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Haemostat Sales Value, by Type (2019-2030)

3.2.3 Global Haemostat Sales Value, by Type (%) (2019-2030)

3.3 Global Haemostat Sales Volume by Type

3.3.1 Global Haemostat Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Haemostat Sales Volume, by Type (2019-2030)

3.3.3 Global Haemostat Sales Volume, by Type (%) (2019-2030)

3.4 Global Haemostat Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 ASCs

4.1.4 Others

4.2 Global Haemostat Sales Value by Application

4.2.1 Global Haemostat Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Haemostat Sales Value, by Application (2019-2030)

4.2.3 Global Haemostat Sales Value, by Application (%) (2019-2030)

4.3 Global Haemostat Sales Volume by Application

4.3.1 Global Haemostat Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Haemostat Sales Volume, by Application (2019-2030)

4.3.3 Global Haemostat Sales Volume, by Application (%) (2019-2030)

4.4 Global Haemostat Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Haemostat Sales Value by Region

5.1.1 Global Haemostat Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Haemostat Sales Value by Region (2019-2024)

5.1.3 Global Haemostat Sales Value by Region (2025-2030)

5.1.4 Global Haemostat Sales Value by Region (%), (2019-2030)

5.2 Global Haemostat Sales Volume by Region

5.2.1 Global Haemostat Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Haemostat Sales Volume by Region (2019-2024)

5.2.3 Global Haemostat Sales Volume by Region (2025-2030)

5.2.4 Global Haemostat Sales Volume by Region (%), (2019-2030)

5.3 Global Haemostat Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Haemostat Sales Value, 2019-2030

5.4.2 North America Haemostat Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Haemostat Sales Value, 2019-2030

5.5.2 Europe Haemostat Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Haemostat Sales Value, 2019-2030

5.6.2 Asia Pacific Haemostat Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Haemostat Sales Value, 2019-2030

5.7.2 South America Haemostat Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Haemostat Sales Value, 2019-2030

5.8.2 Middle East & Africa Haemostat Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Haemostat Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Haemostat Sales Value

6.2.1 Key Countries/Regions Haemostat Sales Value, 2019-2030

6.2.2 Key Countries/Regions Haemostat Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Haemostat Sales Value, 2019-2030

6.3.2 United States Haemostat Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Haemostat Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Haemostat Sales Value, 2019-2030

6.4.2 Europe Haemostat Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Haemostat Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Haemostat Sales Value, 2019-2030

6.5.2 China Haemostat Sales Value by Type (%), 2023 VS 2030

6.5.3 China Haemostat Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Haemostat Sales Value, 2019-2030

6.6.2 Japan Haemostat Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Haemostat Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Haemostat Sales Value, 2019-2030

6.7.2 South Korea Haemostat Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Haemostat Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Haemostat Sales Value, 2019-2030

6.8.2 Southeast Asia Haemostat Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Haemostat Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Haemostat Sales Value, 2019-2030

6.9.2 India Haemostat Sales Value by Type (%), 2023 VS 2030

6.9.3 India Haemostat Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Ethicon

7.1.1 Ethicon Company Information

7.1.2 Ethicon Introduction and Business Overview

7.1.3 Ethicon Haemostat Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Ethicon Haemostat Product Offerings

7.1.5 Ethicon Recent Development

7.2 CSL Behring

7.2.1 CSL Behring Company Information

7.2.2 CSL Behring Introduction and Business Overview

7.2.3 CSL Behring Haemostat Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CSL Behring Haemostat Product Offerings

7.2.5 CSL Behring Recent Development

7.3 Pfizer

7.3.1 Pfizer Company Information

7.3.2 Pfizer Introduction and Business Overview

7.3.3 Pfizer Haemostat Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Pfizer Haemostat Product Offerings

7.3.5 Pfizer Recent Development

7.4 Equimedical BV

7.4.1 Equimedical BV Company Information

7.4.2 Equimedical BV Introduction and Business Overview

7.4.3 Equimedical BV Haemostat Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Equimedical BV Haemostat Product Offerings

7.4.5 Equimedical BV Recent Development

7.5 Davol

7.5.1 Davol Company Information

7.5.2 Davol Introduction and Business Overview

7.5.3 Davol Haemostat Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Davol Haemostat Product Offerings

7.5.5 Davol Recent Development

7.6 Baxter

7.6.1 Baxter Company Information

7.6.2 Baxter Introduction and Business Overview

7.6.3 Baxter Haemostat Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Baxter Haemostat Product Offerings

7.6.5 Baxter Recent Development

7.7 Hemcon Medical Technologies

7.7.1 Hemcon Medical Technologies Company Information

7.7.2 Hemcon Medical Technologies Introduction and Business Overview

7.7.3 Hemcon Medical Technologies Haemostat Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Hemcon Medical Technologies Haemostat Product Offerings

7.7.5 Hemcon Medical Technologies Recent Development

7.8 Ceremed

7.8.1 Ceremed Company Information

7.8.2 Ceremed Introduction and Business Overview

7.8.3 Ceremed Haemostat Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Ceremed Haemostat Product Offerings

7.8.5 Ceremed Recent Development

8 Industry Chain Analysis

8.1 Haemostat Industrial Chain

8.2 Haemostat Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Haemostat Sales Model

8.5.2 Sales Channel

8.5.3 Haemostat Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. Haemostat Market Trends

Table 2. Haemostat Market Drivers & Opportunity

Table 3. Haemostat Market Challenges

Table 4. Haemostat Market Restraints

Table 5. Global Haemostat Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Haemostat Revenue Market Share by Company (2019-2024)

Table 7. Global Haemostat Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Haemostat Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Haemostat Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Haemostat Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Haemostat Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Haemostat

Table 13. Global Haemostat Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemostat as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Haemostat Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Haemostat Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Haemostat Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Haemostat Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Haemostat Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Haemostat Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Haemostat Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Haemostat Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Haemostat Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Haemostat Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Haemostat Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Haemostat Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Haemostat Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Haemostat Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Haemostat Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Haemostat Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Haemostat Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Haemostat Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Haemostat Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Haemostat Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Haemostat Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Haemostat Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Haemostat Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Haemostat Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Haemostat Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Haemostat Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Haemostat Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Haemostat Sales Value by Region (2019-2024) & (%)

Table 44. Global Haemostat Sales Value by Region (2025-2030) & (%)

Table 45. Global Haemostat Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Haemostat Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Haemostat Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Haemostat Sales Volume by Region (2019-2024) & (%)

Table 49. Global Haemostat Sales Volume by Region (2025-2030) & (%)

Table 50. Global Haemostat Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Haemostat Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Haemostat Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Haemostat Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Haemostat Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Haemostat Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Haemostat Sales Volume, (2025-2030) & (K Units)

Table 57. Ethicon Company Information

Table 58. Ethicon Introduction and Business Overview

Table 59. Ethicon Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Ethicon Haemostat Product Offerings

Table 61. Ethicon Recent Development

Table 62. CSL Behring Company Information

Table 63. CSL Behring Introduction and Business Overview

Table 64. CSL Behring Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. CSL Behring Haemostat Product Offerings

Table 66. CSL Behring Recent Development

Table 67. Pfizer Company Information

Table 68. Pfizer Introduction and Business Overview

Table 69. Pfizer Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Pfizer Haemostat Product Offerings

Table 71. Pfizer Recent Development

Table 72. Equimedical BV Company Information

Table 73. Equimedical BV Introduction and Business Overview

Table 74. Equimedical BV Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Equimedical BV Haemostat Product Offerings

Table 76. Equimedical BV Recent Development

Table 77. Davol Company Information

Table 78. Davol Introduction and Business Overview

Table 79. Davol Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Davol Haemostat Product Offerings

Table 81. Davol Recent Development

Table 82. Baxter Company Information

Table 83. Baxter Introduction and Business Overview

Table 84. Baxter Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Baxter Haemostat Product Offerings

Table 86. Baxter Recent Development

Table 87. Hemcon Medical Technologies Company Information

Table 88. Hemcon Medical Technologies Introduction and Business Overview

Table 89. Hemcon Medical Technologies Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Hemcon Medical Technologies Haemostat Product Offerings

Table 91. Hemcon Medical Technologies Recent Development

Table 92. Ceremed Company Information

Table 93. Ceremed Introduction and Business Overview

Table 94. Ceremed Haemostat Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Ceremed Haemostat Product Offerings

Table 96. Ceremed Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Haemostat Downstream Customers

Table 100. Haemostat Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Haemostat Product Picture

Figure 2. Global Haemostat Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Haemostat Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Haemostat Sales Volume (2019-2030) & (K Units)

Figure 5. Global Haemostat Sales Price (2019-2030) & (USD/Unit)

Figure 6. Haemostat Report Years Considered

Figure 7. Global Haemostat Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Haemostat Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Haemostat Revenue in 2023

Figure 10. Haemostat Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Pituitrin Picture

Figure 12. Hemostatic Sensitivity Picture

Figure 13. Others Picture

Figure 14. Global Haemostat Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Haemostat Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Haemostat Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Haemostat Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Haemostat Price by Type (2019-2030) & (USD/Unit)

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Clinic

Figure 21. Product Picture of ASCs

Figure 22. Product Picture of Others

Figure 23. Global Haemostat Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Haemostat Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Haemostat Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Haemostat Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Haemostat Price by Application (2019-2030) & (USD/Unit)

Figure 28. North America Haemostat Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Haemostat Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Haemostat Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Haemostat Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Haemostat Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Haemostat Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Haemostat Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Haemostat Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Haemostat Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Haemostat Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Haemostat Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Haemostat Sales Volume (%), (2019-2030)

Figure 40. United States Haemostat Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Haemostat Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Haemostat Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Haemostat Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Haemostat Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Haemostat Sales Value by Application (%), 2023 VS 2030

Figure 46. China Haemostat Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Haemostat Sales Value by Type (%), 2023 VS 2030

Figure 48. China Haemostat Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Haemostat Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Haemostat Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Haemostat Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Haemostat Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Haemostat Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Haemostat Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Haemostat Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Haemostat Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Haemostat Sales Value by Application (%), 2023 VS 2030

Figure 58. India Haemostat Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Haemostat Sales Value by Type (%), 2023 VS 2030

Figure 60. India Haemostat Sales Value by Application (%), 2023 VS 2030

Figure 61. Haemostat Industrial Chain

Figure 62. Haemostat Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

Related Reports

Global Haemostat Market Research Report 2024
The global Haemostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 82
USD 2900.00
(Single User License)
Global Haemostat Market Insights, Forecast to 2030
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-15
Pages: 87
USD 4900.00
(Single User License)
Global Haemostat Market Research Report 2025
The global market for Haemostat was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 84
USD 2900.00
(Single User License)
Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Haemostat was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 96
USD 3950.00
(Single User License)
Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Haemostat market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 132
USD 4900.00
(Single User License)
Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Haemostat market is projected to grow from US$ 2150 million in 2025 to US$ 3099 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-14
Pages: 177
USD 4900.00
(Single User License)
Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Haemostat market size was US$ 2150 million in 2025 and is forecast to reach a readjusted size of US$ 3099 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-05-14
Pages: 150
USD 4250.00
(Single User License)
Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Haemostat was estimated to be worth US$ 2150 million in 2025 and is projected to reach US$ 3099 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-05-14
Pages: 146
USD 3950.00
(Single User License)
Global Haemostat Market Research Report 2026
The global Haemostat market was valued at US$ 2150 million in 2025 and is anticipated to reach US$ 3099 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-05-14
Pages: 134
USD 2900.00
(Single User License)

Global Haemostat Market Research Report 2024
The global Haemostat market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 82
USD 2900.00 (Single User License)
Global Haemostat Market Insights, Forecast to 2030
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-15
Pages: 87
USD 4900.00 (Single User License)
Global Haemostat Market Research Report 2025
The global market for Haemostat was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 84
USD 2900.00 (Single User License)
Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Haemostat was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 96
USD 3950.00 (Single User License)
Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Haemostat market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
USD 4250.00 (Single User License)
Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Haemostat market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 132
USD 4900.00 (Single User License)
Global Haemostat Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Haemostat market is projected to grow from US$ 2150 million in 2025 to US$ 3099 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-14
Pages: 177
USD 4900.00 (Single User License)
Global Haemostat Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Haemostat market size was US$ 2150 million in 2025 and is forecast to reach a readjusted size of US$ 3099 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-05-14
Pages: 150
USD 4250.00 (Single User License)
Haemostat- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Haemostat was estimated to be worth US$ 2150 million in 2025 and is projected to reach US$ 3099 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-05-14
Pages: 146
USD 3950.00 (Single User License)
Global Haemostat Market Research Report 2026
The global Haemostat market was valued at US$ 2150 million in 2025 and is anticipated to reach US$ 3099 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-05-14
Pages: 134
USD 2900.00 (Single User License)